KB
Kimelman & Baird Portfolio holdings
AUM
$1.23B
This Quarter Return
+4.38%
1 Year Return
+13.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$596M
AUM Growth
+$596M
(+4.9%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
42.83%
Holding
127
New
21
Increased
29
Reduced
43
Closed
9
Top Buys
| 1 |
Waste Connections
WCN
|
$11.7M |
| 2 |
Seagate
STX
|
$11.4M |
| 3 |
Camden National
CAC
|
$3.05M |
| 4 |
Teleflex
TFX
|
$1.34M |
| 5 |
KSU
Kansas City Southern
KSU
|
$679K |
Top Sells
| 1 |
Wells Fargo
WFC
|
$7.57M |
| 2 |
Novartis
NVS
|
$6.97M |
| 3 |
Copart
CPRT
|
$2.74M |
| 4 |
Skyworks Solutions
SWKS
|
$1.55M |
| 5 |
TRIB
Trinity Biotech
TRIB
|
$1.42M |
Sector Composition
| 1 | Industrials | 22.88% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 11.74% |
| 4 | Energy | 10.63% |
| 5 | Communication Services | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
General Dynamics
GD
$87.3B
| $225K | 0.04% |
1,302
-200
| -13% | -$34.6K |
|
102
Alibaba
BABA
$322B
| $220K | 0.04% |
+2,500
| New | +$220K |
|
103
Enterprise Products Partners
EPD
$69.6B
| $216K | 0.04% |
8,000
| – | – |
|
104
Philip Morris
PM
$260B
| $215K | 0.04% |
2,355
-395
| -14% | -$36.1K |
|
105
Verizon
VZ
$186B
| $215K | 0.04% |
4,034
-97
| -2% | -$5.17K |
|
106
Southern Company
SO
$102B
| $207K | 0.03% |
4,204
-410
| -9% | -$20.2K |
|
107
SPDR S&P 500 ETF Trust
SPY
$658B
| $207K | 0.03% |
925
-50
| -5% | -$11.2K |
|
108
Regeneron Pharmaceuticals
REGN
$61.5B
| $202K | 0.03% |
+550
| New | +$202K |
|
|
DISCK
109
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $201K | 0.03% |
+7,500
| New | +$201K |
|
|
ESSX
110
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
| $83K | 0.01% |
486,954
-107,508
| -18% | -$18.3K |
|
111
Peraso
PRSO
$5.42M
| $2K | ﹤0.01% |
10,500
| – | – |
|
112
Biogen
BIIB
$19.4B
| – | – |
-1,000
| Closed | -$313K |
|
113
Duke Energy
DUK
$95.3B
| – | – |
-3,351
| Closed | -$268K |
|
114
Gilead Sciences
GILD
$140B
| – | – |
-2,550
| Closed | -$202K |
|
|
115
Novartis
NVS
$245B
| – | – |
-88,262
| Closed | -$6.97M |
|
116
Pfizer
PFE
$141B
| – | – |
-5,933
| Closed | -$201K |
|
|
TRIB
117
Trinity Biotech
TRIB
$5.44M
| – | – |
-107,367
| Closed | -$1.42M |
|
|
118
Wells Fargo
WFC
$263B
| – | – |
-170,938
| Closed | -$7.57M |
|
|
AGN
119
DELISTED
Allergan plc
AGN
| – | – |
-885
| Closed | -$204K |
|